Ranolazine and Nitrol drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Ranolazine (ranolazine) and Nitrol (nitroglycerin). Common drug interactions include gastrointestinal disorder among females and retinal detachment among males.

The phase IV clinical study analyzes what interactions people have when they take Ranolazine and Nitrol. It is created by eHealthMe based on reports of 16 people who take the same drugs from the FDA, and is updated regularly.

What is Ranolazine?

Ranolazine has active ingredients of ranolazine. eHealthMe is studying from 9,939 Ranolazine users. Check the latest studies of Ranolazine.

What is Nitrol?

Nitrol has active ingredients of nitroglycerin. eHealthMe is studying from 3,069 Nitrol users. Check the latest studies of Nitrol.

On Jul, 07, 2026

16 people who take Ranolazine and Nitrol together, and have interactions are studied.

Ranolazine and Nitrol drug interactions.

What are the common drug interactions of Ranolazine and Nitrol, by gender? *:

female:

Gastrointestinal disorder (functional problems of gastrointestinal tract)
Anaemia (lack of blood)
Angina pectoris (chest pain due to ischemia of the heart muscle)
Asthenia (weakness)
Contusion (a type of hematoma of tissue in which capillaries)
Diarrhoea
Eosinophilia (eosinophil count in the peripheral blood exceeds)
Haematoma (collection of blood outside the blood vessels)
Hospitalisation
Impaired gastric emptying

male:

Retinal detachment (a disorder of the eye in which the retina peels away from its underlying layer of support tissue)
Anaemia (lack of blood)
Cough
Dysphagia (a condition in which swallowing is difficult or painful)
Fatigue (feeling of tiredness)
Headache (pain in head)
Hiccups (an involuntary spasm of the diaphragm and respiratory organs, with a sudden closure of the glottis and a sound like a cough)
Hyperglycaemia (high blood sugar)
Hypokalaemia (low potassium)
Hypotension (abnormally low blood pressure)

What are the common drug interactions of Ranolazine and Nitrol, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Gastrointestinal disorder (functional problems of gastrointestinal tract)
Hospitalisation
Impaired gastric emptying

60+:

Anaemia (lack of blood)
Cardiac failure
C-reactive protein increased
Contusion (a type of hematoma of tissue in which capillaries)
Cough
Dysphagia (a condition in which swallowing is difficult or painful)
Dyspnoea exertional (breathlessness or shortness of breath)
Eosinophilia (eosinophil count in the peripheral blood exceeds)
Fatigue (feeling of tiredness)
Haematoma (collection of blood outside the blood vessels)

What are the existing conditions these people have? *

Stable Angina (a constant chest pain): 5 people, 31.25%
High Blood Pressure: 5 people, 31.25%
Coronary Heart Disease (narrowing or blockage of the coronary arteries): 3 people, 18.75%
Hyperlipidaemia (presence of excess lipids in the blood): 2 people, 12.50%
Sleep Disorder: 2 people, 12.50%
Chest Pain: 2 people, 12.50%
Diabetes: 2 people, 12.50%
Dyspnea (difficult or laboured breathing): 2 people, 12.50%
Type 2 Diabetes: 1 person, 6.25%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 1 person, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Ranolazine and Nitrol?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously